spot_img
15 C
London
HomeTRENDING NEWSNovo Nordisk Warns of First Sales Drop Since Start of Ozempic

Novo Nordisk Warns of First Sales Drop Since Start of Ozempic

The once high-flying Danish drugmaker has struggled to fend off rivals in the weight-loss industry, especially Eli Lilly, which gave a much rosier outlook to investors.

spot_img

latest articles

explore more